首页> 外文期刊>Therapeutic advances in drug safety. >Tramadol-induced hiccups: a case–noncase study in the European pharmacovigilance database
【24h】

Tramadol-induced hiccups: a case–noncase study in the European pharmacovigilance database

机译:曲马多诱导的打嗝:欧洲药物检修数据库中的一个案例

获取原文
           

摘要

Background: Hiccups are usually benign and self-limiting, but can sometimes be persistent. If left untreated, they can provoke severe discomfort, and even death. Hiccups can be idiopathic, organic, psychogenic, and caused by drugs. Although some case reports have suggested a possible association between tramadol and hiccups, to our knowledge, no study has analyzed this possible relationship. The aim of this study was to analyze whether a disproportionate number of cases of hiccups are reported for tramadol in the EudraVigilance database. Methods: A case–noncase study was conducted to assess the association between hiccups and tramadol, calculating reporting odds ratios (RORs) from 1 January 1995 to 11 September 2020. Cases were selected using the preferred term ‘Hiccups’. The noncases used as controls were all other adverse drug reaction reports recorded in EudraVigilance during the same period. Exposure was defined as exposure to tramadol among cases and noncases. To reduce the risk of confounding by indication, the RORs for tramadol compared with other opioids were obtained. Additionally, we performed a confirmatory analysis in the World Health Organization pharmacovigilance database, VigiBase ? . Results: There were 3089 cases of hiccups in the 7,213,623 reports. Tramadol was involved in 50 cases. The ROR for tramadol exposure was 3.35 [95% confidence interval (CI) 2.53–4.43]. This association persisted when comparing tramadol with other opioids; ROR: 2.13 (95% CI 1.52–2.99). Disproportionality was also observed in VigiBase ? : ROR 1.69 (95% CI 1.47–1.93). Conclusion: Our study confirms, for the first time, a possible signal for a tramadol–hiccups association. Nevertheless, observational analytical studies are needed to confirm these results Plain Language Summary Evaluation of the relationship between the tramadol and the risk of hiccups Introduction: Hiccups are sudden involuntary contractions of the diaphragm. This involuntary contraction causes the vocal cords to close very briefly, which produces the characteristic sound of a hiccup. Hiccups are usually benign and self-limiting, but can sometimes be persistent. If left untreated, they can provoke severe discomfort, depression, disability, and in the most extreme cases, even death. Drugs are a rare cause of hiccups. Methods: This study investigated the possible association between tramadol and hiccups (an unmentioned adverse drug reaction in the Summary of Product Characteristics) in the European pharmacovigilance database (EudraVigilance) and a confirming analysis in the World Health Organization pharmacovigilance database (VigiBase). Results: Our analysis shows that hiccups is relatively more frequently reported in association with tramadol than with other medicinal products, with EudraVigilance and VigiBase confirming this association. Conclusion: Tramadol is an opioid analgesic indicated, alone or in combination with dexketoprofen or paracetamol for pain with various causes, so healthcare professionals and patients should be aware of this possible association.
机译:背景:打嗝通常是良性和自我限制的,但有时可能是持久的。如果没有治疗,他们可以挑起严重的不适,甚至死亡。打嗝可以是特发性,有机,心理和药物引起的。虽然有些案例报告提出了曲马多和打嗝之间可能的关联,但对于我们的知识,没有研究过这种可能的关系。本研究的目的是分析eudravibilance数据库中的曲马多的曲折症是否讨论了不成比例的杂种病例。方法:进行案例 - 非背包研究,以评估杂皮瓶和曲马多的关联,从1995年1月1日至9月11日开始计算报告赔率比(ROR)。使用优选的术语“特征”选择病例。用作对照的非共产值是在同一时期内以eudravigilance记录的所有其他不良药物反应报告。暴露被定义为患情况和非必需的曲马多。为了降低暗示诱发的风险,获得与其他阿片类药物相比的曲马多的ROR。此外,我们在World Health Adjows Pharmacogilance数据库中进行了确认分析,Vigibase? 。结果:7,213,623次报告中有3089例打嗝。曲马多参与了50例。曲马多暴露的ROR为3.35 [95%置信区间(CI)2.53-4.43]。在将曲马多与其他阿片类药物相比,这种关联持续存在; ROR:2.13(95%CI 1.52-2.99)。在vigibase中也观察到不成比例? :ROR 1.69(95%CI 1.47-1.93)。结论:我们的研究首次证实了曲马多发式关联的可能信号。尽管如此,需要观察分析研究来确认这些结果简单语言概要评估曲马多与打嗝的风险引言:封闭是隔膜的突然不自主的收缩。这种无意识的收缩使声带非常短暂地关闭,这产生了打嗝的特征声。打嗝通常是良性和自我限制的,但有时可能是持久的。如果没有治疗,他们可以引发严重的不适,抑郁,残疾,以及最极端的情况,甚至死亡。药物是罕见的打嗝原因。方法:本研究调查了曲马多和打嗝之间的可能关联(在欧洲药物文献数据库(Eudravigilance)和世界卫生组织药物检测数据库(Primibase)的确认分析中进行了确认分析。结果:我们的分析表明,与其他药品相比,打嗝比与其他药品相比,与其他药品相比,eudravipilance和vigibase证实了这一协会。结论:Tarmadol是一种表明,单独或与Dexketoprofen或扑热氨基酚的疼痛组合,用于各种原因,因此医疗保健专业人员和患者应该了解这一可能的关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号